Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience


Pricing
Go Premium Now
Login
Best Dividend Stocks
Ex-Dividend Dates
High Yield Stocks
Strategies
Tools
Articles
Premium
Advisors
Guaranteed Income

Biotech Researcher

News

The Big Dividend Play in Big Biotech

Aaron Levitt Jul 04, 2018


Healthcare remains one of the most exciting and dynamic sectors in the entire market.

Demand remains steady and, thanks to plenty of innovation, lifespans continue to grow. That, in turn, is driving more demand for healthcare solutions. Perhaps the most exciting sub-segment of the healthcare industry is biotech stocks.

But for many investors, biotech still represents a “lotto ticket” proposition. The sector is littered with failures, missed opportunities and evaporating capital. To that end, most conservative investors take a pass on the sector.

However, that could be a poor decision.

The reality is, many of the top biotech stocks are dividend machines – pumping out billions in cash flows and sales from blockbuster drugs. For investors, these dynamic firms offer a great combination of growth and income.

Read more about why you need to think about healthcare costs.

To read the Full Story, Go Premium or Log in

Popular Articles